Oregon became the latest state to address “Right to Try Laws� by passing a bill that contradicts an FDA restriction on experimental drug use in terminal patients, known as the “Oregon Right to Try Act�.

The Next Generation ACO Model offers expanded financial incentives that increase performance risk for greater reward. See this post for more information.

Since the inception of the Health Care Fraud and Abuse Control Program, it has returned more than $27.8 billion to the Medicare Trust Fund. See this post for more information.

The Food and Drug Administration (FDA) has issued final guidance on labeling reusable medical devices in the wake of a UCLA Medical Center "super-bug" outbreak. See this post for details.

The U.S. House passed a bipartisan bill to overhaul the Medicare payment system on March 26, 2015. See this post for more details.

Looking to stay informed on the most recent developments in health law and policy? Check out this post for details about a local health law professional's weekly podcast.

Check out this post to read more about the recent decision in Indiana Patient’s Compensation Fund v. Holcomb and how it could affect your practice and clients.

Please join us for the 2015 Hall Center for Law & Health/Indiana Health Law Review Symposium: Medical Myths: Exploring Scientific Rigor, Effectiveness and Misinformation on Friday, March 27 from 8:45 a.m. to 3:15 p.m.

Earlier this month, the CMS announced a voluntary Self-Referral Disclosure Protocol that will allow physician owned hospitals and rural providers an alternative means to address non-compliance with the federal Stark Laws. See this post for more details.

Earlier this week, the United States Supreme Court heard 85 minutes of arguments relating to a second major challenge to the Affordable Care Act. Find out more in this post.